What Resources are Available to Providers?
AIM with Immunotherapy offers a wide variety of helpful resources for healthcare professionals in this section of our website. From continuing medical education opportunities to healthcare provider toolkits to a list of immunotherapy drugs by tumor type, there is a lot of information to explore.
This section of the AIM with Immunotherapy website features:
- Blog posts on contemporary issues related to the management and understanding of immunotherapy
- Care Step Pathways to recognize and then address immune-related adverse events (irAEs)
- Continuing medical education (CME) opportunities offered through our partnerships
- Drugs listed by tumor type
- Healthcare provider toolkits that provide information on drug management
- Immunotherapy news briefs and summaries
- Information on ctDNA testing and monitoring for response to immunotherapy
- A Facebook provider community
- Information on healthcare disparities
- Videos about irAEs from faculty discussing the clinical management of irAEs and guidance on communicating with patients
Immunotherapies are broadly defined on these pages as:
- Antibody-drug conjugates (ADCs)
- Bispecific antibodies
- Bispecific T-cell engagers (BiTEs)
- Chimeric antigen receptor (CAR) T-cell therapy
- Cytokines
- Immune checkpoint inhibitors (ICIs)
- Monoclonal antibodies
- Oncolytic virotherapy
- Tumor-infiltrating lymphocyte (TIL) therapy
- Vaccines
Why trust AIM’s resources?
Our resources are written with guidance and assistance from the latest medical information in high-impact medical journals, governing bodies, regulatory agencies, and reputable sources. The initial writing is done at the PhD level and then passed to multiple editors. The polished written content is then thoroughly reviewed by licensed medical professionals who are experts in the specific area of medicine and treatment. Nothing is created in isolation.